Kevin Aissa

Q: What is Kevin Aissa email address?

Email Kevin Aissa at karthuraissa@gmail.com and kaissa@c-3i.com. This email is the most updated Kevin Aissa's email found in 2026.

Q: How to contact Kevin Aissa?

To contact Kevin Aissa send an email to karthuraissa@gmail.com or kaissa@c-3i.com. (updated on September 28, 2024)

Project Manager at C3i | Canada

About Kevin Aissa

Kevin Aissa is a dynamic Project Manager at C3i, where he leverages his extensive background in carbohydrate-protein chemistry and biolytical experience to drive the commercialization of cutting-edge cell and gene therapies. With a PhD thesis focusing on carbohydrate-protein interactions, Kevin possesses a deep understanding of the biochemical principles that underpin therapeutic development. His journey from research to market has been marked by significant contributions to the development of HCV and COVID-19 diagnostic tests, showcasing his ability to translate complex scientific concepts into viable commercial products.

At C3i, Kevin plays a pivotal role in overseeing critical projects that span the entire lifecycle of cell and gene therapies—from initial clinical trials to regulatory approval and process optimization. His current focus on achieving the first Drug Establishment License (DEL) for cell therapy in Canada reflects his commitment to advancing innovative treatments that can transform patient outcomes. Kevin’s expertise in bioengineering, combined with his strong management skills, enables him to effectively coordinate cross-functional teams and streamline project workflows.

In addition to his technical acumen, Kevin is proficient in a variety of software tools, including Microsoft Office Suite, which he utilizes for statistical data analysis and strategic commercial planning. His ability to synthesize complex data into actionable insights ensures that projects remain aligned with both regulatory requirements and market needs. With a passion for advancing healthcare solutions, Kevin Aissa is not only a key player at C3i but also a thought leader in the field of biopharmaceutical commercialization.

Kevin Aissa Work